Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kalafatis

Showing results (11-20 of 179) with videos related to

Pageof 18
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 7, 2011
Cleavage at both Arg306 and Arg506 is required and sufficient for timely and efficient inactivation of factor Va by activated protein CMelissa A Barhoover, Michael Kalafatis
The Journal of Biological Chemistry|December 25, 1993
Role of the membrane in the inactivation of factor Va by activated protein CM Kalafatis, K G Mann
Anticancer Research|December 4, 2018
Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast CancerJasmine M Manouchehri, Michael Kalafatis
The Journal of Biological Chemistry|March 30, 2001
The role of the membrane in the inactivation of factor va by plasmin. Amino acid region 307-348 of factor V plays a critical role in factor Va cofactor functionM Kalafatis, K G Mann
Biochemistry|October 16, 2002
Identification of a binding site for blood coagulation factor Xa on the heavy chain of factor Va. Amino acid residues 323-331 of factor V represent an interactive site for activated factor XMichael Kalafatis, Daniel O Beck
The Journal of Applied Laboratory Medicine|July 8, 2020
The Case Back on the TRAIL: Death Receptors as Markers for rhTRAIL SensitivityKatherine A Turner, Michael Kalafatis
Anticancer Research|December 1, 2017
Sensitization of rhTRAIL-resistant Triple-negative Breast Carcinoma Through Silibinin Co-TreatmentJasmine M Manouchehri, Michael Kalafatis
Journal of Bacteriology|August 23, 2021
Long-Distance Effects of H-NS Binding in the Control of <i>hilD</i> Expression in the Salmonella SPI1 LocusMarinos Kalafatis, James M Slauch
International Surgery|October 1, 1982
Temporary ileal cecostomyB G Leoutsakos, G C Kalafatis
Therapeutic Advances in Psychopharmacology|July 3, 2020
Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agentsDelia Bishara, Chris Kalafatis, David Taylor
Pageof 18

Showing results (11-20 of 179) with videos related to

Sort By:
Pageof 18
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 7, 2011
Cleavage at both Arg306 and Arg506 is required and sufficient for timely and efficient inactivation of factor Va by activated protein CMelissa A Barhoover, Michael Kalafatis
The Journal of Biological Chemistry|December 25, 1993
Role of the membrane in the inactivation of factor Va by activated protein CM Kalafatis, K G Mann
Anticancer Research|December 4, 2018
Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast CancerJasmine M Manouchehri, Michael Kalafatis
The Journal of Biological Chemistry|March 30, 2001
The role of the membrane in the inactivation of factor va by plasmin. Amino acid region 307-348 of factor V plays a critical role in factor Va cofactor functionM Kalafatis, K G Mann
Biochemistry|October 16, 2002
Identification of a binding site for blood coagulation factor Xa on the heavy chain of factor Va. Amino acid residues 323-331 of factor V represent an interactive site for activated factor XMichael Kalafatis, Daniel O Beck
The Journal of Applied Laboratory Medicine|July 8, 2020
The Case Back on the TRAIL: Death Receptors as Markers for rhTRAIL SensitivityKatherine A Turner, Michael Kalafatis
Anticancer Research|December 1, 2017
Sensitization of rhTRAIL-resistant Triple-negative Breast Carcinoma Through Silibinin Co-TreatmentJasmine M Manouchehri, Michael Kalafatis
Journal of Bacteriology|August 23, 2021
Long-Distance Effects of H-NS Binding in the Control of <i>hilD</i> Expression in the Salmonella SPI1 LocusMarinos Kalafatis, James M Slauch
International Surgery|October 1, 1982
Temporary ileal cecostomyB G Leoutsakos, G C Kalafatis
Therapeutic Advances in Psychopharmacology|July 3, 2020
Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agentsDelia Bishara, Chris Kalafatis, David Taylor
Pageof 18